Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Submitted by
admin
on November 12, 2023 - 9:30pm
Source:
Motley Fool
News Tags:
Merck
Bristol Myers Squibb
antibody-drug conjugate
Headline:
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
snippet:
Merck and Bristol Myers Squibb are developing antibody-drug conjugates.
Both are acquiring biotechs and assets to beef up their pipelines.
Investment in research and development (R&D) today will be the deciding factor for the next 10 years.
Do Not Allow Advertisers to Use My Personal information
